Key Trends Nutraceuticals Market

Nutraceutical Actives: What Manufacturers and Suppliers Need to Know

Consumers’ mounting health concerns, rapidly growing aging populations, the occurrence of chronic diseases, and the willingness to replace pharmaceutical agents are driving the market for nutraceutical actives in Europe and the United States.

The territories are two of the three key regional markets for nutraceutical actives, together accounting for around USD 8 billion; the U.S market is estimated to be higher in value.  

Other reasons for the market increases include healthy lifestyles focusing on wellness, along with the rising number of gymand fitness enthusiasts. Continue reading

Empty Hard Capsules The Impact of COVID-19

Empty Hard Capsules: What Is the Contrasting Impact of COVID-19 on Regional Markets?

Empty hard capsules (EHCs) are an effective alternative to the traditionally used tablet dosage forms in the pharmaceutical and nutrition industries. Despite having some disadvantages, such as higher costs and advanced technical requirements for manufacturing, hard capsules provide better dosage options for hygroscopic drugs, greater patient compliance, and are versatile dosage forms. Consequently, hard capsules were the second-leading oral solid-dosage form worldwide in 2020, after tablets. Continue reading

biologics excipients and ingredients market

Growth of Biologics and Biosimilars Will Drive Above-Average Demand for a Range of Ingredients

A surging number of biologic APIs and their growing penetration into multiple therapies create an attractive market segment for pharmaceutical ingredient suppliers but not one without challenges, analyzes Kline’s recently published Biologics: Market Opportunities for Chemicals Suppliers. To learn about key findings from the study, REGISTER for a complimentary webinar, taking place on October 17, 2019.

Currently, more than 350 biologics are commercially presented in the biopharmaceuticals market. Some established biologics, such as Humira and Avastin, maintained their growth of the last decade in 2018, with sales growing by 8.2% and 9.5%, respectively. New drugs such as Opdivo, which was first introduced in 2017, witnessed particularly robust growth in the overall biopharmaceutical market.Continue reading

blog

Kline Confirms that Excipients are on the Rise in a New Era for Biologics and Topicals

Biologics:

The global pharmaceutical industry is facing a surge biologics. In recent years, biologic drugs have enjoyed a better approval rating than traditional drugs, as biologic drugs have been found to treat major chronic and complex diseases with higher safety and efficacy. The global production of biologics is expected to grow at a rate of around 10% annually.Continue reading

Synthetic Latex Polymers

Performance vs. Cost: Demand Trends in Synthetic Latex Polymers

The market of synthetic latex polymers assumes a unique set of characteristics in every geography, from performance of the economy, purchasing power of the population, and industrialization to demand patterns, competition from alternate technologies, and performance of the polymers in specific end uses.

North America and China both represent the largest markets of synthetic latex polymers by volume, each accounting for an approximate 25% share of global consumption. Meanwhile, India, which has a much smaller share of around 5% of global consumption, is the fastest-growing market for synthetic latex polymers in the world. It is these three key geographical markets of North America, China, and India that Kline studies in depth this year in its continuous Synthetic Latex Polymers Global Series: Business Analysis and Opportunities program.Continue reading